Aion Therapeutic Inc. (ANTCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0038
0.00 (0.00%)
At close: Dec 23, 2024
Aion Therapeutic Income Statement
Financials in millions CAD. Fiscal year is May - April.
Millions CAD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 | 2019 - 2018 |
| Revenue | 0.8 | 0.37 | - | - | - | - | Upgrade
|
| Cost of Revenue | 0.45 | 0.2 | - | - | 0 | - | Upgrade
|
| Gross Profit | 0.36 | 0.16 | - | - | -0 | - | Upgrade
|
| Selling, General & Admin | 1.56 | 1.26 | 0.84 | 1.37 | 2 | 0.85 | Upgrade
|
| Research & Development | - | - | - | 0.95 | - | - | Upgrade
|
| Operating Expenses | 1.64 | 1.3 | 0.86 | 2.39 | 2.6 | 0.96 | Upgrade
|
| Operating Income | -1.28 | -1.14 | -0.86 | -2.39 | -2.6 | -0.96 | Upgrade
|
| Interest Expense | -0.19 | -0.17 | -0.15 | -0.08 | -0.19 | -0.32 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.01 | -0.01 | -0.11 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.08 | -0.05 | 0.17 | 0.08 | -0.17 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.05 | -0.12 | -0.43 | -0.17 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -1.45 | -1.41 | -1.07 | -2.82 | -3.13 | -1.32 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -2.54 | - | Upgrade
|
| Asset Writedown | -2.01 | -2.01 | 0.25 | -1 | -2.6 | - | Upgrade
|
| Other Unusual Items | -2.86 | -2.86 | 0.56 | - | - | 0.65 | Upgrade
|
| Pretax Income | -6.33 | -6.29 | -0.26 | -3.82 | -8.27 | -0.67 | Upgrade
|
| Net Income | -6.33 | -6.29 | -0.26 | -3.82 | -8.27 | -0.67 | Upgrade
|
| Net Income to Common | -6.33 | -6.29 | -0.26 | -3.82 | -8.27 | -0.67 | Upgrade
|
| Shares Outstanding (Basic) | 341 | 265 | 146 | 140 | 94 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 341 | 265 | 146 | 140 | 94 | 36 | Upgrade
|
| Shares Change (YoY) | 131.73% | 81.07% | 4.65% | 48.98% | 161.64% | 30.62% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.00 | -0.03 | -0.09 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.00 | -0.03 | -0.09 | -0.02 | Upgrade
|
| Free Cash Flow | -1.15 | -0.85 | -0.04 | -1.35 | -2.13 | -0.76 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Gross Margin | 44.44% | 44.39% | - | - | - | - | Upgrade
|
| Operating Margin | -159.40% | -310.32% | - | - | - | - | Upgrade
|
| Profit Margin | -788.87% | -1710.90% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -143.88% | -229.96% | - | - | - | - | Upgrade
|
| EBITDA | - | -1.13 | -0.84 | -2.33 | -2.47 | -0.85 | Upgrade
|
| D&A For EBITDA | - | 0.01 | 0.02 | 0.07 | 0.13 | 0.11 | Upgrade
|
| EBIT | -1.28 | -1.14 | -0.86 | -2.39 | -2.6 | -0.96 | Upgrade
|
| Advertising Expenses | - | 0.05 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.